MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics 
HOOKIPA to Participate in the JMP Securities Life Sciences Conference
NEW YORK and VIENNA, Austria, June 09, 2022 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing...
Palette Life Sciences Announces FDA 510(k) Clearance for Barrigel® Rectal Spacer, Proven Safe and Effective at Minimizing the Harmful Long-Term Side Effects of Prostate Radiation Therapy
Groundbreaking technology introduces increased control to achieve optimal coverage proven to significantly reduce the risk of toxicity to the rectumSANTA...
SpringWorks Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
STAMFORD, Conn., June 09, 2022 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing...
Mydecine Provides Company Update; Welcomes New Board Member
DENVER, June 09, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the...
BioCryst Selects Pint Pharma as Commercial Partner for ORLADEYO® (berotralstat) in Latin America
RESEARCH TRIANGLE PARK, N.C., June 09, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the company has entered...
Tonix Pharmaceuticals Announces Data Presentations Involving TNX-1500 (Fc-modified anti-CD40L mAb) for the Prevention of Rejection in Kidney and Heart Allograft Transplantation in Animal Models at the 2022 American Transplant Congress
Research Directed by Faculty of the Center for Transplantation Sciences, Massachusetts General HospitalCHATHAM, N.J., June 09, 2022 (GLOBE NEWSWIRE) --...
BioAdaptives, Inc. Reveals Corporate Strategy for a Strengthened Market Presence, Through Empowerment of Seniors, as Nutraceutical Market Surpasses $454 Billion USD
Management Pursues Growth By Bringing Advanced Wellness Through Advantageous Senior Pricing LAS VEGAS, NV, June 09, 2022 (GLOBE NEWSWIRE) --...
Mesoblast Key Opinion Leader Event Series for Investors & Analysts
Chronic Low Back Pain due to Degenerative Disc DiseaseNEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB),...
Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman
NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company...
Exavir Therapeutics announces publication of preclinical data for ultra-long-acting dolutegravir prodrug XVIR-120
Ultra-long-acting plasma pharmacokinetics and biodistribution to tissues of interest demonstrated in three species Injections were well tolerated with no adverse...
Satsuma Pharmaceuticals Announces Five Abstracts Accepted for Presentation at The American Headache Society’s 64th Annual Scientific Meeting
Oral Presentation: Initial Data from ASCEND Study Highlights STS101’s Long-Term Safety and TolerabilitySOUTH SAN FRANCISCO, Calif., June 09, 2022 (GLOBE...
Nova Mentis and University of Central Florida to Develop Saliva Serotonin Assay
Vancouver, British Columbia--(Newsfile Corp. - June 9, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)...
Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO)
ARLINGTON, Va.--(BUSINESS WIRE)--The Medical Device Innovation Consortium (MDIC) today announced that Andrew Fish, JD has been appointed as President and...
BioFuse Medical Technologies Welcomes New Member, Joseph Stauffer, DO, MBA, FAPCR to the Board of Directors
MELBOURNE, FL / ACCESSWIRE / June 8, 2022 / BioFuse Medical Technologies, Inc., an emerging surgical device company with transformative...
CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform
Acquisition extends CureVac's capabilities and adds key competencies to further accelerate oncology strategy for new therapies that enable patients' immune...
Love Pharma Inc. Announces First Closing of Financing
VANCOUVER, BC / ACCESSWIRE / June 8, 2022 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0), announces it...
CureVac Announces Changes of CDO – Myriam Mendila to Succeed Klaus Edvardsen
Myriam Mendila appointed as Chief Development Officer starting from February 1, 2023Klaus Edvardsen returning to Denmark after holding numerous leadership...
Novamind Shareholders Approve Proposed Acquisition by Numinus
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this...
Cloud DX Signs Fourth Paramedicine Provider; contracts signed have increased 142% YoY
Fourth Emergency Medicine Services (EMS) contract in 2022 as more EMS choose the Cloud DX Virtual Care PlatformKITCHENER, ON /...
Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 8, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (Neovasc or the Company) today...